OSELTAMIVIR PHOSPHATE (oseltamivir phosphate) by Jubilant Therapeutics is [see microbiology ( )] . Approved for acute, uncomplicated illness due to influenza a, b infection in patients 2 weeks of age and 3 more indications. First approved in 2024.
Drug data last refreshed 19h ago
[see Microbiology ( )] .
Worked on OSELTAMIVIR PHOSPHATE at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects